Experimental Animal Models in Neurological Diseases

dc.authorscopusid59204825400en_US
dc.authorscopusid7006702494en_US
dc.contributor.authorŞirin, N.
dc.contributor.authorDemir, Ş.
dc.date.accessioned2024-08-23T16:07:30Z
dc.date.available2024-08-23T16:07:30Z
dc.date.issued2024en_US
dc.departmentDüzce Üniversitesien_US
dc.description.abstractThe human brain is a structure that controls billions of neurons and trillions of connections. Having a unique anatomy with countless neurons and connections makes its understanding even more complex. The brain, divided into different regions for specialized functions such as memory, movement, sensation, and emotions, holds great significance in human cognition and behavior. Centuries of research, coupled with advancements in technology, have propelled neuroscience forward, facilitating the understanding of the neurological, behavioral, and structural characteristics of the brain. Developing treatments for neurological disorders such as Alzheimer's, Parkinson's, multiple sclerosis, amyotrophic lateral sclerosis, migraine, epilepsy, and schizophrenia as well as understanding the complex mechanisms of these diseases, require the exploration of new treatment methods, drugs, and products through direct experimentation on humans, which raises ethical concerns. Therefore, experimental animal models are needed in the treatment of neurodegenerative diseases. There are currently many experimental animal models developed to elucidate the pathophysiological characteristics of neurological disorders. The aim of this review was to summarize the experimental models of neurodegenerative diseases developed today in sections. While recognizing that an experimental animal model may not fully replicate the disease process in humans, it can at least provide guidance in understanding the disease. © 2024, Duzce University Medical School. All rights reserved.en_US
dc.identifier.doi10.18678/dtfd.1481630
dc.identifier.endpage64en_US
dc.identifier.issn1307-671X
dc.identifier.issueS1en_US
dc.identifier.scopus2-s2.0-85197477159en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage55en_US
dc.identifier.urihttps://doi.org/10.18678/dtfd.1481630
dc.identifier.urihttps://hdl.handle.net/20.500.12684/14695
dc.identifier.volume26en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherDuzce University Medical Schoolen_US
dc.relation.ispartofDüzce Tıp Fakültesi Dergisi
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectexperimental animal modelsen_US
dc.subjectNeurological diseasesen_US
dc.subjectadulten_US
dc.subjectAlzheimer diseaseen_US
dc.subjectamyotrophic lateral sclerosisen_US
dc.subjectanimal modelen_US
dc.subjectcontrolled studyen_US
dc.subjectdegenerative diseaseen_US
dc.subjectdrug analysisen_US
dc.subjectdrug combinationen_US
dc.subjectdrug therapyen_US
dc.subjectepilepsyen_US
dc.subjecthumanen_US
dc.subjectkinesthesiaen_US
dc.subjectmigraineen_US
dc.subjectmotor neuron diseaseen_US
dc.subjectmultiple sclerosisen_US
dc.subjectnerve cellen_US
dc.subjectneurologic diseaseen_US
dc.subjectnonhumanen_US
dc.subjectParkinson diseaseen_US
dc.subjectreviewen_US
dc.subjectschizophreniaen_US
dc.titleExperimental Animal Models in Neurological Diseasesen_US
dc.title.alternativeNörolojik Hastalıklarda Deneysel Hayvan Modellerien_US
dc.typeReviewen_US

Dosyalar